NOVATO, Calif., Feb. 7, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will present a company update at the BIO CEO & Investor Conference in New York on Tuesday, February 14, 2012 at 9:00 a.m. ET.
